Edgewell Personal Care Co. (EPC) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2025 (Fiscal Q3 2025) and the nine months ended June 30, 2025. Edgewell Personal Care is a global manufacturer of personal care products operating in three segments: Wet Shave (Schick, Wilkinson Sword), Sun and Skin Care (Banana Boat, Hawaiian Tropic, Jack Black), and Feminine Care (Playtex, Stayfree, Carefree). The company is a large accelerated filer with operations in approximately 20 countries.
Key Financial Metrics
| Metric ($ millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $627.2 | $647.8 | $1,686.3 | $1,736.1 |
| Gross Profit | $268.5 | $287.1 | $716.3 | $742.9 |
| Gross Margin % | 42.8% | 44.3% | 42.5% | 42.8% |
| Operating Income | $53.7 | $82.7 | $132.9 | $178.9 |
| Net Earnings | $29.1 | $49.0 | $56.0 | $89.8 |
| Diluted EPS | $0.62 | $0.98 | $1.17 | $1.79 |
| Operating Cash Flow (9M) | $44.3 | $157.3 | - | - |
| Free Cash Flow (9M) | ($5.1) | $126.7 | - | - |
| Total Debt | $1,403.2 | $1,308.5 | - | - |
| Cash & Equivalents | $199.6 | $209.1 | - | - |
Note: Free Cash Flow calculated as Operating Cash Flow minus Capital Expenditures ($49.4M for 9M 2025).
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3.2% in Q3 and 2.9% for the nine months. Organic sales declined 4.2% in Q3 and 2.5% for the nine months, driven by volume declines in North America (Wet Shave, Sun Care, Feminine Care) and increased promotional levels.
- Profitability Pressure: Operating income dropped 35% in Q3 and 26% for the nine months. Gross margin contracted 150 basis points in Q3 due to core inflation, volume absorption, and unfavorable currency impacts, partially offset by productivity savings.
- Restructuring Charges: Significant increase in restructuring charges to $16.0M in Q3 (vs. $3.1M prior year) and $32.4M for the nine months (vs. $13.1M). These relate to operating model redesign and the consolidation of Mexico facilities.
- Segment Performance:
- Wet Shave: Sales flat (+0.2%), profit down 7.4%.
- Sun and Skin Care: Sales down 5.3%, profit down 28.3% due to weather-related volume declines and higher marketing spend.
- Feminine Care: Sales down 10.5%, profit down 31.8% due to declines in pads and tampons.
- Capital Allocation: Share repurchases accelerated to $90.2M for the nine months (vs. $40.2M prior year). Only 0.2 million shares remain under the current authorization.
Guidance, Outlook, and Risks
- Restructuring Outlook: Management expects to incur approximately $44M in pre-tax restructuring charges for fiscal 2025. The Mexico facility consolidation is expected to be completed by Q2 fiscal 2026.
- Impairment Risk: A triggering event was identified for the Feminine Care reporting unit. An interim impairment analysis was performed; fair value exceeded carrying value by less than 10%, resulting in no charge. However, management notes that unfavorable fluctuations in discount rates or forecasted sales could result in impairment in the future.
- Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) was enacted on July 4, 2025. The company is assessing the impact, with certain provisions effective beginning fiscal 2026.
- Liquidity: The company maintains $289.9M in available revolver capacity. Management believes cash on hand and borrowing capacity are sufficient for the next 12 months.
Investor Verification Checklist
- Feminine Care Valuation: Verify the sensitivity of the Feminine Care goodwill valuation given the narrow margin (less than 10%) between fair value and carrying value.
- North America Volume Trends: Confirm the sustainability of volume declines in North America across Wet Shave and Sun Care segments amidst increased promotional activity.
- Restructuring Execution: Monitor the timeline and cost realization of the Mexico facility consolidation and operating model redesign to ensure charges align with the $44M fiscal 2025 estimate.
- Share Repurchase Authorization: Note that the current buyback program is nearly exhausted (0.2M shares remaining); verify if a new authorization will be sought.
- Working Capital Impact: Investigate the $82.7M negative change in operating assets and liabilities contributing to the significant drop in operating cash flow.